March 4 (Reuters) - Opus Genetics Inc IRD.O:
OPUS GENETICS- IN JAN, GOT PARAGRAPH IV CERTIFICATION NOTICE FROM WINSTON & STRAWN, COUNSEL TO SANDOZ INCORPORATED
OPUS GENETICS- SANDOZ SUBMITTED ANDA TO FDA SEEKING APPROVAL TO MANUFACTURE GENERIC VERSION OF RYZUMVITM IN US PRIOR EXPIRATION OF SIX PATENTS